What Are Peptides, and How Do They Work?

The short answer

A peptide is a short chain of amino acids linked by peptide bonds, the same chemical link that holds proteins together, just fewer of them: most sources put the cutoff around 100 amino acids, above which a chain is classed as a protein rather than a peptide.

That’s the whole peptides vs proteins distinction: same building blocks, different length. How do peptides work? Mainly as signaling molecules, instructing cells to release hormones, regulate immune activity, repair tissue, or manage inflammation, rather than serving as structural material the way most proteins do.

Some peptides are FDA-approved drugs with decades of clinical use behind them (insulin, GLP-1 medications like semaglutide). Others are sold as “research” compounds or wellness products with little to no human trial data, only test-tube or animal studies, and manufacturing that isn’t independently verified.

Types of peptides span this whole range: endogenous peptides your body already makes, dietary peptides broken down from food protein, oral peptide supplements, topical (skincare) peptides, and injectable peptides used off-label or in gray-market contexts.

This guide covers many individual examples in depth, including BPC-157, TB-500, and GHK-Cu Peptide, alongside goal-based roundups like Best Peptides for Weight Loss and Best Peptides for Recovery.

The short answer: peptides aren’t one thing, safe or unsafe, effective or not. Whether a given peptide is well-studied, medically regulated, or essentially an unproven experiment depends entirely on which peptide, which source, and what evidence actually exists for it, which is why the rest of this guide treats each compound and category separately rather than making a blanket claim.

What we are actually talking about

A peptide is a short chain of amino acids linked together by peptide bonds, the same chemical bond that holds proteins together.

What is a peptide, in the simplest terms: amino acids are the building blocks, and a peptide bond is the link between one amino acid and the next, formed when the body (or a chemist) joins them end to end. Chain length is what separates the terms.

Once that chain gets long enough, roughly past 100 amino acids, it stops being called a peptide and starts being called a protein. Peptides vs proteins, then, is really a question of size rather than a difference in the basic chemistry.

How do peptides work: most act as signaling molecules. A peptide binds to a receptor on a cell’s surface and tells that cell to do something specific, release a hormone, start repairing tissue, ramp up an immune response, or slow down inflammation.

Insulin is the clearest example of this in everyday medicine: a 51-amino-acid peptide made by the pancreas that tells cells to take up glucose.

Types of peptides fall into a few overlapping categories: those made naturally inside the body, those obtained from food, and those synthesized in a lab. Chains are also sometimes grouped by size, with shorter oligopeptides and longer polypeptides, though sources differ slightly on exactly where that line falls.

Within these categories sit very different products: FDA-approved drugs like insulin and GLP-1 medications, well-studied dietary peptide supplements such as collagen, and a separate, unregulated category of injectable peptides (BPC-157, TB-500, GHK-Cu Peptide) sold outside standard drug approval channels.

That last distinction, approved medicine versus unregulated product, is the one most readers searching this phrase are actually trying to sort out, and it shapes everything else this guide covers.

How it works

Amino acids link together through a peptide bond, a chemical bond formed when the acid group of one amino acid joins the amine group of the next, releasing a water molecule in the process.

String enough of these bonds together and you get a peptide; keep going past roughly 100 amino acids and the chain is classified as a protein instead, per WebMD and Hawaii Pacific Health. That size cutoff, not a different chemistry, is the main line dividing peptides vs proteins.

How do peptides work once they’re in the body? Most act as signaling molecules. A peptide’s specific sequence and shape let it fit a matching receptor on a cell’s surface, the way a key fits a lock.

That binding event tells the cell to do something: release insulin, trigger tissue repair, dial down inflammation, or send a hormonal signal elsewhere in the body. Different peptides target different receptor systems, which is why the effects attributed to peptides range from blood sugar regulation to skin collagen production to immune signaling.

Sources describe several types of peptides by structure or origin:

Oral peptide supplements face a practical mechanical limit: digestion breaks most ingested peptides down into individual amino acids before they can act as intact signaling molecules, according to WebMD and an NYP endocrinologist.

This is one reason researchers and manufacturers have favored injectable delivery for peptides meant to reach the bloodstream intact, a distinction covered in more depth in the Best Peptides for Recovery and Best Peptides for Skin guides.

What the evidence actually shows

Evidence for peptides splits sharply by category, and the strength of that evidence is the single most useful thing to know before reading further.

That table captures the core split answering “how do peptides work” in practice: some peptides act through mechanisms confirmed in large human studies, and others are still hypotheses supported by preclinical data.

For the types of peptides most searched, the evidence base varies by use case rather than by peptide class alone.

Oral peptide supplements, including most peptide supplements sold as capsules or powders, are broken down during digestion into amino acids, which is why injectable routes are used for compounds like BPC-157 or TB-500 when recovery claims are made, despite the underlying evidence for those specific compounds remaining animal-study grade.

Combination use, such as the BPC-157 + TB-500 Wolverine Stack, has no dedicated clinical trials behind it at all.

Topical use, as with GHK-Cu Peptide, has more consumer-facing research than injectable use of the same compound, since one injectable form was pulled over impurity concerns while topical formulations remained available.

The pattern across categories: FDA-approved peptide drugs sit on strong evidence, oral collagen supplements sit on moderate evidence, and gray-market injectable peptides sit on weak, preclinical evidence regardless of how popular they are online.

The risks

The adverse-effect picture splits cleanly along the same line as the evidence itself: FDA-approved peptide drugs have documented, monitored side-effect profiles, while gray-market injectable peptide supplements rely on scattered anecdotal reports collected outside any formal surveillance system.

For approved peptide medicines (insulin, GLP-1 drugs like semaglutide), side effects are well characterized through clinical trials and post-market reporting: nausea, gastrointestinal upset, and injection-site reactions are common and expected, with known frequency and severity ranges.

For unregulated peptides sold as “research use only”, the picture is thinner. Sources describing use of compounds like BPC-157 and TB-500 report a similar cluster of anecdotal effects: nausea, diarrhea, headache, fatigue, and localized injection-site irritation or reactions.

These are self-reported patterns from users and clinicians observing users, not findings from controlled trials, so their true incidence is unknown.

Two specific concerns go beyond routine side effects. One sports-medicine source raises a theoretical worry that peptides could activate dormant or undiagnosed cancer cells, a concern that has not been tested and remains speculative.

Separately, combining multiple unregulated peptides at once, a practice sometimes called “stacking” (as with the BPC-157 + TB-500 Wolverine Stack), introduces interaction risks that no source has studied at all.

The explicit gap: no large-scale human safety trials exist for most gray-market peptide supplements. Manufacturing purity is unverified, long-term effects are unknown, and a Harvard-affiliated researcher who studies dietary supplements has stated plainly that using them amounts to self-experimentation rather than medicine with a known safety margin.

Who should be cautious

Some populations have a specific, mechanism-based reason for added caution beyond the general risk profile already described.

This is not an exhaustive list of every type of peptide sold as a supplement, and it does not replace the general safety limits already noted.

One recurring theme across sources is that the mechanism of concern is usually specific to a person’s own history (cancer risk, competitive status, existing medication) rather than a property of peptides as a class.

Oral peptide supplements carry a separate, more mechanical caution: digestion breaks the peptide bond before most of the molecule reaches the bloodstream intact, which is why the products discussed above are largely injectable rather than oral.

Where the law stands

The legal status of a given peptide depends entirely on which of three regulatory lanes it falls into, and that lane can change without much public notice.

FDA-approved peptide drugs (insulin, GLP-1 medications like semaglutide and tirzepatide, tesamorelin, and roughly 100 others) sit in the same regulatory category as any prescription medicine: manufacturing standards, clinical trial data, and labeling requirements all apply.

Oral peptide supplements, including collagen peptides, are regulated more loosely as dietary supplements rather than drugs, which is a separate and less stringent framework.

The third lane is the one causing most of the confusion: injectable peptides such as BPC-157, TB-500, and the combination sold as the BPC-157 + TB-500 Wolverine Stack are not FDA-approved drugs.

At least one source (Columbia) describes the FDA classifying several of these as “Category 2 bulk drug substances,” a designation flagging significant safety concerns for compounding.

They are typically sold labeled “for research purposes only,” which is a real legal distinction, not a loophole phrase: it is what permits the sale of the raw chemical while making it not legal to market for human use or consumption.

Enforcement does shift. One documented example: WebMD reports the FDA banned the injectable form of copper peptide (GHK-Cu) in September 2023 over impurities linked to immune reactions, while topical GHK-Cu in skincare was not affected. Separately, WADA lists growth hormone secretagogue peptides as banned substances for competing athletes, regardless of their FDA status.

Because enforcement actions and approvals change, treat any specific legal claim here as a snapshot rather than a permanent fact, and verify current status before relying on it.

Frequently asked questions